Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
272 Leser
Artikel bewerten:
(0)

Hospital for Special Surgery Invests in Sectra Orthopaedic 3D Planning Software for Improved Surgical Outcomes

LINKÖPING, Sweden and SHELTON,Connecticut, Jan. 16, 2018 /PRNewswire/ --

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that Hospital for Special Surgery (HSS), one of the most renowned orthopaedic hospitals in the US, has ordered Sectra's 3D pre-operative planning solution. The software will provide HSS orthopaedic surgeons with advanced tools to enhance visualization of complex cases with the goal of improving patient outcomes.

"Sectra's innovative 3D solutions will enable us to make full use of the acquired images, resulting in cutting edge delivery of care to our orthopaedic patients," says William M. Ricci, MD, Chief of Orthopaedic Trauma Service at HSS. "This 3D platform will improve the quality of pre-operative planning with potential for improved surgical outcomes."

The 3D pre-operative planning solution includes tools that allow the surgeon to render standard CT images into a three-dimensional interactive image that can be segmented, manipulated, mirrored, templated and 3D printed. The software will integrate with the existing Sectra radiology PACS at HSS to enable surgeons immediate access from anywhere in the hospital.

"This agreement adds software tools for advanced 3D virtual fracture reduction and trauma planning as well as efficient tools for 3D spine planning into the hands of all surgeons at HSS," says Gustaf Schwang, General Manager Business Unit Orthopaedics at Sectra. "It also includes collaborative development of software, intended to deepen both companies' leadership position in our respective markets."

Video: Sectra's 3D Trauma Pelvic

Sectra at AAOS
Visit Sectra at booth #3967 where the orthopaedic solution will be showcased.
Read more and secure your meeting with Sectra at AAOS.

About Sectra Enterprise Imaging
With more than 25 years of innovation and 1,700 installations, Sectra is a leading global provider of imaging IT solutions that support healthcare in achieving patient-centric care.

The orthopaedic solution is part of Sectra's complete enterprise imaging offering which is comprised of PACS for imaging-intense departments-radiology, orthopaedics, pathology and cardiology, VNA and Cross Enterprise Workflow solutions. Using the same technical platform, customers can easily extend a departmental solution to create a comprehensive VNA and enterprise image management solution without major investments or the replacement of existing components.

Read more about Sectra and why Sectra PACS is "Best in KLAS" at http://www.sectra.com/medical/.

For further information, please contact:
Dr. Torbjörn Kronander
CEO and President SectraAB
+46 (0) 705-23-52-27

Gustaf Schwang
General Manager of Business Unit Orthopeadics at Sectra
+46 (0) 734-16-08-10

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/sectra/r/hospital-for-special-surgery-invests-in-sectra-orthopaedic-3d-planning-software-for-improved-surgica,c2430898

The following files are available for download:

http://news.cision.com/sectra/i/sectra-3d-pelvic-module,c2320569

Sectra 3D pelvic module

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.